Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rochelle P Walensky

Showing results (1-10 of 314) with videos related to

Pageof 32
Sort By:
Emerging Infectious Diseases|December 10, 2022
Partnerships, Collaborations, and Investments Integral to CDC's International Response to COVID-19Rochelle P Walensky
Current HIV/AIDS Reports|June 26, 2013
Combination HIV prevention: the value and interpretation of mathematical modelsRochelle P Walensky
The Journal of Infectious Diseases|September 23, 2017
Please Pass the Peanut ButterRochelle P Walensky
JAMA|May 6, 2010
A piece of my mind. DisclosureRochelle P Walensky
Public Health Reports (Washington, D.C. : 1974)|April 6, 2023
Gratitude for Public Health: COVID-19 and BeyondRochelle P Walensky
Annals of Internal Medicine|April 26, 2016
Investing in People Who Inject Drugs: A PrEPonderance of OpportunitiesRochelle P Walensky
Topics in HIV Medicine : a Publication of the International AIDS Society, USA|November 6, 2009
Cost-effectiveness of HIV interventions: from cohort studies and clinical trials to policyRochelle P Walensky
AIDS Clinical Care|January 19, 2007
APTIMA assay approved for HIV testingRochelle P Walensky
Annals of Emergency Medicine|June 21, 2011
Cost-effectiveness analysis and HIV screening: the emergency medicine perspectiveHeather Hsu, Rochelle P Walensky
BMJ (Clinical Research Ed.)|September 3, 2020
Covid-19: re-opening universities is high riskGavin Yamey, Rochelle P Walensky
Pageof 32

Showing results (1-10 of 314) with videos related to

Sort By:
Pageof 32
Emerging Infectious Diseases|December 10, 2022
Partnerships, Collaborations, and Investments Integral to CDC's International Response to COVID-19Rochelle P Walensky
Current HIV/AIDS Reports|June 26, 2013
Combination HIV prevention: the value and interpretation of mathematical modelsRochelle P Walensky
The Journal of Infectious Diseases|September 23, 2017
Please Pass the Peanut ButterRochelle P Walensky
JAMA|May 6, 2010
A piece of my mind. DisclosureRochelle P Walensky
Public Health Reports (Washington, D.C. : 1974)|April 6, 2023
Gratitude for Public Health: COVID-19 and BeyondRochelle P Walensky
Annals of Internal Medicine|April 26, 2016
Investing in People Who Inject Drugs: A PrEPonderance of OpportunitiesRochelle P Walensky
Topics in HIV Medicine : a Publication of the International AIDS Society, USA|November 6, 2009
Cost-effectiveness of HIV interventions: from cohort studies and clinical trials to policyRochelle P Walensky
AIDS Clinical Care|January 19, 2007
APTIMA assay approved for HIV testingRochelle P Walensky
Annals of Emergency Medicine|June 21, 2011
Cost-effectiveness analysis and HIV screening: the emergency medicine perspectiveHeather Hsu, Rochelle P Walensky
BMJ (Clinical Research Ed.)|September 3, 2020
Covid-19: re-opening universities is high riskGavin Yamey, Rochelle P Walensky
Pageof 32